Efficacy of pegylated interferon-α treatment for 24 months in chronic delta hepatitis and predictors of response
- Authors:
- C Karaca, OM Soyer, B Baran, AC Ormeci, S Gokturk, E Aydin, S Evirgen, ...
- Journal:
- Antivir Ther 18 (4), 561-6
- Publication Year:
- 2013
- Citations:
- 51
- Subject Area:
- Viral Hepatitler
No verified DOI was found for this publication. The Google Scholar record is shown as the source.
Other Publications in This Subject Area
- The association with histopathological findings and predictive significance of transforming growth factor beta 1 (TGF Β1) in patients with chronic viral hepatitis (2023)
- Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study (2022)
- OĞUZ KAĞAN BAKKALOĞLU (2022)
- Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data (2022)
- Changing epidemiology of chronic hepatitis C: patients are older and at a more advanced stage at the time of diagnosis (2019)
This list was extracted from Prof. Dr. Çetin Karaca's public Google Scholar profile; DOI matches were verified against CrossRef. Citation counts reflect Google Scholar's data at extraction time and are not updated in real time.
← Back to Viral Hepatitler publications